Clinic
Grande Ronde Hospital, INC.
Grande Ronde Hospital, INC. was paid $20.12M by Medicaid between Jan 2018 and Nov 2024, across 152 billing codes. Its largest line is 99284, emergency room visit (serious) — 32% of everything it billed.
33Billing provider infoGRANDE RONDE HOSPITAL, INC.
LA GRANDE, OR 97850
LA GRANDE, OR 97850
33aNPI1467446195assigned 09/08/2005
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$20.12M
24GClaims214,618
24DCodes billed152
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Oregon
Rank by total paid#5 of 40
Median peer was paid$517K
This provider vs. median39×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,537 | $2.60M | |
| 2019 | 26,308 | $2.43M | |
| 2020 | 28,797 | $2.33M | |
| 2021 | 35,630 | $2.91M | |
| 2022 | 37,271 | $3.23M | |
| 2023 | 33,779 | $3.47M | |
| 2024incomplete | 28,296 | $3.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 24,353 | 16,808 | $6.45M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 28,324 | 20,102 | $5.35M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 6,226 | 4,473 | $2.42M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.4% | 18,692 | 11,581 | $1.09M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.3% | 16,557 | 11,043 | $861K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 9,257 | 7,120 | $839K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.0% | 1,313 | 927 | $403K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 3,135 | 2,727 | $282K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.1% | 2,085 | 1,524 | $224K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 2,158 | 1,586 | $191K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,561 | 2,081 | $180K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 849 | 535 | $169K |
140 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,457 | $124K |
| 99205 | Prolong outpt/office vis | <1% | 932 | $123K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,480 | $105K |
| 80053 | Comprehensive metabolic panel | <1% | 20,681 | $104K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,331 | $79K |
| 95886 | <1% | 381 | $78K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,669 | $78K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,443 | $72K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,100 | $60K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,345 | $53K |
| 73630 | <1% | 1,646 | $53K | |
| 20610 | <1% | 1,062 | $51K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,451 | $44K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,463 | $41K |
| 01810 | <1% | 207 | $33K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 831 | $29K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 402 | $29K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,151 | $26K |
| 64721 | <1% | 26 | $24K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 587 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 173 | $22K |
| J2704 | Injection, propofol, 10 mg | <1% | 921 | $22K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 221 | $19K |
| 87631 | <1% | 177 | $17K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 306 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 131 | $14K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,703 | $14K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 468 | $13K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 33 | $13K |
| 81001 | <1% | 6,117 | $11K | |
| 83605 | <1% | 2,051 | $11K | |
| 95910 | <1% | 85 | $10K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 712 | $10K |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 133 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,940 | $9K |
| 80061 | Lipid panel | <1% | 1,348 | $8K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 606 | $8K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 237 | $8K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 80 | $8K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 249 | $8K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 307 | $7K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 813 | $7K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 61 | $6K |
| 76857 | <1% | 115 | $6K | |
| 84484 | <1% | 1,332 | $6K | |
| 69210 | <1% | 182 | $5K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 13 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 175 | $5K |
| 86850 | <1% | 460 | $5K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 29 | $5K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 117 | $5K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 23 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 106 | $4K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 48 | $4K |
| 95816 | <1% | 24 | $4K | |
| 59025 | Fetal non-stress test | <1% | 54 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 144 | $4K |
| 95800 | <1% | 16 | $4K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 286 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 34 | $3K |
| 31231 | <1% | 22 | $3K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 12 | $3K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 19 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 163 | $3K |
| 92567 | <1% | 89 | $3K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 96 | $3K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 101 | $3K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 59 | $3K |
| 85027 | <1% | 670 | $2K | |
| 95115 | <1% | 215 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 146 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 28 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 30 | $2K |
| 11102 | <1% | 12 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 80 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 80 | $2K |
| 00142 | <1% | 18 | $2K | |
| 73564 | <1% | 77 | $2K | |
| 95117 | <1% | 76 | $2K | |
| 20553 | <1% | 226 | $2K | |
| 83735 | <1% | 473 | $2K | |
| 83690 | <1% | 376 | $2K | |
| 81025 | <1% | 260 | $1K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 58 | $1K |
| 80306 | <1% | 144 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 431 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $1K |
| 73110 | <1% | 76 | $1K | |
| 73130 | <1% | 68 | $1K | |
| C1780 | Lens, intraocular (new technology) | <1% | 18 | $1K |
| 92588 | <1% | 16 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 34 | $1K |
| 87400 | <1% | 174 | $1K | |
| 84145 | <1% | 137 | $1K | |
| 87081 | <1% | 219 | $1K | |
| 95885 | <1% | 23 | $1K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 31 | $938.59 |
| 11721 | <1% | 72 | $931.18 | |
| 99406 | <1% | 64 | $925.65 | |
| 73610 | <1% | 65 | $880.92 | |
| 86140 | <1% | 386 | $826.17 | |
| 81002 | <1% | 457 | $814.11 | |
| 92504 | <1% | 20 | $700.78 | |
| 87634 | <1% | 13 | $683.84 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 162 | $662.63 |
| 73030 | <1% | 30 | $634.29 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 64 | $628.29 |
| 86803 | <1% | 59 | $449.55 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 12 | $434.64 |
| 87806 | <1% | 12 | $407.50 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 26 | $387.78 |
| 93244 | <1% | 14 | $366.45 | |
| 85652 | <1% | 314 | $365.11 | |
| 86780 | <1% | 38 | $342.11 | |
| 20552 | <1% | 100 | $327.13 | |
| 85610 | <1% | 159 | $282.09 | |
| 86900 | <1% | 137 | $278.52 | |
| 86901 | <1% | 137 | $274.34 | |
| 85730 | <1% | 75 | $263.67 | |
| 93227 | <1% | 13 | $258.10 | |
| 87340 | <1% | 37 | $256.99 | |
| 93296 | <1% | 12 | $233.74 | |
| 86762 | <1% | 25 | $231.61 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13 | $228.06 |
| 82728 | <1% | 27 | $209.88 | |
| 85379 | <1% | 20 | $201.64 | |
| 83880 | <1% | 17 | $191.67 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 14 | $177.63 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $157.68 |
| 81003 | <1% | 123 | $149.99 | |
| 82607 | <1% | 24 | $147.84 | |
| 83550 | <1% | 30 | $141.63 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 18 | $130.30 |
| 85018 | <1% | 65 | $102.92 | |
| 83540 | <1% | 30 | $99.66 | |
| 84439 | <1% | 12 | $75.72 | |
| 82570 | <1% | 15 | $25.41 | |
| 82043 | <1% | 12 | $24.30 | |
| 99024 | 0% | 700 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, JEREMY (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Grande Ronde Hospital, INC. | La Grande, OR | $231K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.